Day: February 26, 2026

Nasdaq Copenhagen                                                                                    Nikolaj Plads 6DK-1067 Copenhagen K    Copenhagen, 26 February 2026ANNOUNCEMENT no. 3/2026 Managers’ transactions Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 26 February 2026.Details of the person discharging managerial responsibilities/person closely associated  Name: Jarosław LipińskiReason for the notification:  Position/status: CEO in Cemat A/SInitial notification/Amendment: InitialDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  Name: Cemat A/SLEI: 213800899MWAZT9KQZ78      Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type...

(In United States dollars, except where noted otherwise) TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) — First Quantum Minerals Ltd. (“First Quantum” or the “Company”) (TSX: FM) announces that it has completed its offering of $1,500 million aggregate principal amount of 6.375% senior notes due 2036 (the “Notes”). The Notes are senior unsecured obligations of the Company and are guaranteed by certain of the Company’s subsidiaries. Interest on the Notes will accrue from the issue date and will be payable semi-annually. The Company intends to apply the gross proceeds from the sale of the Notes, together with cash on balance sheet, to redeem in full its $1,350 million aggregate principal amount outstanding of existing 9.375% senior secured second lien notes due 2029, to repay certain drawn revolving credit facility amounts and to pay...

SUPPLEMENTARY INFORMATION (CORRECTIVE INFORMATION) TO THE ANNUAL REPORT 2024 AND THE INTERIM REPORT FOR H1 2025 Hørsholm 26 February 2026 Company announcement #1 Pharma Equity Group A/S (the “Company”) hereby publishes the effects of a correction to the Company’s annual report for 2024 as well as the interim report for the first half of 2025. TABLE OF CONTENTSBackground to the corrective information Management’s statement Independent auditor’s report Correction to the consolidated financial statements for 2024a. Income statementb. Balance sheetc. Statement of changes in equityd. Cash flow statemente. NotesCorrection to the parent company financial statements for 2024a. Income statementb. Balance sheetc. Statement of changes in equityd. Cash flow statemente. NotesCorrection to the interim financial statements for the first half...

LONG BEACH, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) — The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report fourth quarter and full year 2025 financial results after market close on Thursday, March 12, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company’s investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure InformationThe Beauty Health Company announces material information to the public through a variety of means, including filings with the Securities and Exchange Commission,...

AUGA group, RAB (legal entity code 126264360, hereinafter – the Company) announces that on 26 February 2026, the Company signed the Share Purchase and Sale Agreement to sell 100% of RUAB ‘Baltic Champs’ (legal entity code 302942064, hereinafter – ‘Baltic Champs’) shares to Global Champs, UAB (legal entity code 307494558, hereinafter – the Buyer). “The sale of ‘Baltic Champs’ shares marks the implementation of the first of four key actions from the court-approved AUGA group restructuring plan, which, thanks to the Buyer’s motivation, the approach of the responsible authorities, and the goodwill of creditors, we were able to achieve ahead of the scheduled timeline. This action is aimed at restoring the liquidity of the Company and its group companies (hereinafter – the Group), significantly reducing the overall Group debt level, and eliminating...

DENVER, Feb. 26, 2026 (GLOBE NEWSWIRE) — Vista Gold Corp. (NYSE American and TSX: VGZ) (“Vista” or the “Company”) is pleased to announce the pricing of its previously announced underwritten public offering of 15,600,000 of its common shares at a price to the public of US$2.50 per share. The total gross proceeds to Vista are expected to be US$39.0 million, before deducting underwriting discounts and commission and other offering expenses payable by Vista. The offering is expected to close on March 9, 2026, subject to the satisfaction of customary closing conditions, including the approval of the NYSE American and the Toronto Stock Exchange. In addition, Vista has granted the underwriters a 30-day option to purchase up to an additional 2,340,000 common shares, to cover over-allotments, if any. The Company intends to allocate the...